Testosterone Cypionate Cost in New Hampshire (2026): Cash, Insurance, and Compounded Pricing

What Does Testosterone Cypionate Actually Cost in New Hampshire Right Now?

The generic 200 mg/mL testosterone cypionate vial (1 mL) averages $60 per month at New Hampshire retail pharmacies without insurance in 2026. Brand-name Depo-Testosterone carries a manufacturer list price near $100 per month, though very few patients pay list. Pharmacy-to-pharmacy variation across NH can swing prices by 20% to 35%, so comparing quotes between chains like CVS, Walgreens, and independent pharmacies in Manchester, Nashua, or Concord is worth the five minutes it takes.

Discount platforms such as GoodRx, RxSaver, and SingleCare frequently bring the out-of-pocket cost for a 1 mL vial of generic testosterone cypionate down to $30 to $45 in New Hampshire. These coupons are free and accepted at most retail pharmacies. They cannot be combined with insurance, but for patients whose copay exceeds $45, the coupon alone may be the better deal.

The Endocrine Society's 2018 clinical practice guideline recommends testosterone cypionate as a first-line injectable option for male hypogonadism, reinforcing its place as a workhorse therapy. That guideline status keeps generic supply strong and prices relatively stable compared to newer formulations like testosterone nasal gel or oral testosterone undecanoate, both of which cost $400 or more per month without coverage.

A 10 mL multi-dose vial (200 mg/mL), when available, drops the per-dose cost even further. At roughly $90 to $120 for 10 mL, a patient on 100 mg per week gets approximately 10 weeks of therapy from a single vial, working out to $9 to $12 per week. Not every pharmacy stocks the 10 mL size, so call ahead.

New Hampshire Medicaid and Testosterone Cypionate: What's Covered

New Hampshire Medicaid does not cover testosterone cypionate for male hypogonadism as of 2026. This exclusion applies to both brand and generic formulations. Patients enrolled in NH Medicaid who have a clinical diagnosis of hypogonadism confirmed by two morning serum testosterone levels below 300 ng/dL per Endocrine Society thresholds will need to explore alternative payment pathways.

The lack of Medicaid coverage in New Hampshire is not unusual. Several states exclude testosterone replacement therapy from their preferred drug lists unless the indication is a specific FDA-approved condition beyond "low T," such as Klinefelter syndrome, pituitary disease, or chemotherapy-induced hypogonadism. The FDA-approved prescribing information for testosterone cypionate lists primary and hypogonadotropic hypogonadism as the approved indications.

Patients denied Medicaid coverage have a few concrete options. First, apply for a manufacturer patient assistance program. Second, use a discount coupon at a retail pharmacy to pay the $30 to $45 cash price. Third, consider a 503A compounding pharmacy, discussed below.

For patients with dual eligibility (Medicare plus Medicaid), Medicare Part D may cover testosterone cypionate with prior authorization and step therapy. The Centers for Medicare & Medicaid Services formulary search tool can confirm plan-specific coverage.

Commercial Insurance Coverage in New Hampshire

Most commercial insurers operating in New Hampshire, including Anthem, Cigna, Harvard Pilgrim, and Ambetter, cover generic testosterone cypionate on their formularies. Prior authorization is the norm. The typical requirements are straightforward: two morning total testosterone levels below 300 ng/dL drawn on separate days, documented signs or symptoms of hypogonadism, and no absolute contraindications such as untreated polycythemia or active breast or prostate cancer.

Copays on commercial plans in NH generally fall between $10 and $30 for a 30-day supply of generic testosterone cypionate under a preferred tier. Brand Depo-Testosterone, when the generic is available, is almost always placed on a non-preferred or specialty tier with a higher copay, sometimes $75 or more. There is rarely a clinical reason to insist on brand when the generic is bioequivalent.

The Endocrine Society's guideline notes that "testosterone therapy in men with hypogonadism should aim to restore serum testosterone to the mid-normal range" [1]. Insurance authorization criteria in NH align closely with this guideline: confirm the deficiency with lab work, document symptoms, and prescribe within the labeled indication.

If a prior authorization is denied, request a peer-to-peer review. New Hampshire's Insurance Department allows external review appeals for coverage denials under RSA 420-J. The entire process typically resolves within 30 to 45 days.

Compounded Testosterone Cypionate in New Hampshire: Legality, Pricing, and What to Watch

Compounded testosterone cypionate from a licensed 503A pharmacy is legal in New Hampshire. A 503A pharmacy compounds a patient-specific prescription from a licensed prescriber. This is distinct from 503B outsourcing facilities, which produce larger batches without patient-specific prescriptions and ship across state lines.

Compounded testosterone cypionate in NH averages $80 per month. That price is higher than the $30 to $45 coupon price for manufactured generic, and this raises a fair question: why would anyone choose compounded? Three scenarios make compounding relevant.

First, patients who need a non-standard concentration or a combination product (for example, testosterone cypionate plus anastrozole in a single injection) may require compounding. Second, patients with allergies to inactive ingredients in the manufactured product, such as benzyl benzoate or cottonseed oil, can get a formulation with a different carrier oil like grapeseed or sesame. Third, during periodic manufacturer shortages, compounded product can bridge the gap.

The FDA's guidance on 503A compounding requires that compounded drugs are not copies of commercially available products unless there is a documented clinical difference for the specific patient. New Hampshire's Board of Pharmacy oversees 503A compliance at the state level. Patients should verify that their compounding pharmacy holds a current NH Board of Pharmacy license and uses USP 797 and USP 800 standards for sterile compounding.

One caution: compounded products do not undergo FDA approval or batch-level potency verification the way manufactured generics do. The T-Trials (NEJM 2016, N=790) used manufactured testosterone gel, not compounded injectables, to establish efficacy data. No large randomized trial has specifically evaluated compounded testosterone cypionate. This does not mean compounded product is ineffective, but it does mean the evidence base is thinner.

Telehealth Prescribing: Getting Testosterone Cypionate Without an In-Person Visit in NH

Telehealth prescribing of testosterone cypionate is legal in New Hampshire. The state's telemedicine laws, updated during the COVID-19 public health emergency and made permanent through subsequent legislation, allow a licensed prescriber to evaluate a patient via synchronous audio-video visit and prescribe Schedule III controlled substances, which includes testosterone cypionate.

The prescriber must hold a valid New Hampshire medical license or be authorized under an interstate compact. The DEA requires that the prescriber have a DEA registration, and the Ryan Haight Act permits telemedicine prescribing when a valid practitioner-patient relationship is established via a qualifying platform.

Several telehealth-first TRT clinics operate in New Hampshire. Pricing models vary. Some charge a monthly membership ($99 to $199 per month) that bundles the consultation, lab orders, and medication. Others charge a consultation fee ($50 to $150) plus the pharmacy cost of the medication separately. For patients who already have a primary care provider willing to manage TRT, the most cost-effective path is often a single telehealth consultation with an endocrinologist or urologist for the initial workup, then ongoing management with the PCP.

Lab monitoring on TRT typically includes total testosterone, hematocrit, PSA (for men over 40), and a lipid panel at baseline, 3 months, 6 months, and then annually per Endocrine Society 2018 guidelines [1]. Quest Diagnostics and Labcorp both have draw sites across NH, and many telehealth platforms include lab orders in their fee.

How to Find the Lowest Price in New Hampshire: A Step-by-Step Approach

Start with the generic. Brand Depo-Testosterone offers no clinical advantage over FDA-rated bioequivalent generics manufactured by companies like Teva, Hikma, and Sun Pharma.

Check coupon prices first. Enter your ZIP code on GoodRx, RxSaver, or Cost Plus Drugs (Mark Cuban's pharmacy) and compare the testosterone cypionate 200 mg/mL 1 mL vial price at pharmacies near you. In NH, this typically returns results between $30 and $55.

If you have insurance, compare your copay to the coupon price. If your Tier 1 generic copay is $10, use insurance. If your copay is $50 or more, use the coupon instead. You cannot stack both.

Ask about the 10 mL vial. Not every pharmacy carries it, and not every prescriber writes for it. But the per-dose savings are substantial. At $100 for 10 mL, a patient on 0.5 mL (100 mg) per week gets 20 weeks of therapy for $5 per week.

Consider mail-order pharmacy. Express Scripts, CVS Caremark, and Amazon Pharmacy all ship to NH addresses and sometimes offer lower pricing than brick-and-mortar. Amazon Pharmacy's cash-pay pricing on testosterone cypionate has been consistently competitive in 2025 and 2026.

If you need compounded product for a legitimate clinical reason (allergen avoidance, non-standard dose, combination formulation), get quotes from at least two 503A pharmacies. Help Pharmacy, Hallandale Compounding, and several NH-local compounders are options. Verify the pharmacy's state license and ask whether they follow USP 797 sterile compounding standards.

What the T-Trials Tell Us About Whether TRT Is Worth the Cost

The landmark Testosterone Trials (TtRIALS), published in the New England Journal of Medicine in 2016, enrolled 790 men aged 65 and older with serum testosterone below 275 ng/dL and symptoms of hypogonadism. After 12 months of testosterone gel versus placebo, the testosterone group showed statistically significant improvements in sexual function, walking distance (the Physical Function Trial), and vitality. The mood and cognitive sub-trials showed more modest effects [2].

Dr. Peter Snyder of the University of Pennsylvania, the principal investigator, stated: "The benefits of testosterone treatment were moderate and varied across the different trial outcomes."

A separate cardiovascular safety trial, TRAVERSE (NEJM 2023, N=5,246), followed men with hypogonadism and established or high-risk cardiovascular disease for a mean of 33 months. The primary composite endpoint of major adverse cardiovascular events was non-inferior for testosterone versus placebo (hazard ratio 0.96 to 95% CI 0.78 to 1.17) [3]. This trial resolved years of uncertainty about cardiovascular risk that followed the FDA's 2015 labeling update requiring a cardiovascular warning on all testosterone products.

For New Hampshire patients weighing whether TRT is "worth it" at $30 to $80 per month, these trials provide the most direct answer available: testosterone replacement produces real but moderate symptom improvement in men with confirmed hypogonadism, and the cardiovascular safety profile is reassuring over a 3-year horizon.

Monitoring Costs That Add to the Total Price of TRT in New Hampshire

The medication itself is only part of the annual cost. Baseline and follow-up labs add $100 to $300 per panel without insurance, depending on the lab and whether you use a direct-to-consumer service like Quest's QuestDirect or an online lab-order platform. With commercial insurance, lab copays are typically $0 to $40 per draw.

The Endocrine Society guideline recommends checking hematocrit at baseline, 3 to 6 months, and then annually. Hematocrit above 54% warrants dose reduction or temporary cessation [1]. PSA monitoring for men over 40 is standard. A lipid panel at baseline and 6 to 12 months rounds out the surveillance.

Supplies matter too. Syringes, needles, and alcohol swabs cost $5 to $15 per month if you self-inject at home. Most pharmacies sell these over the counter in New Hampshire without a separate prescription. Using a 25- to 27-gauge needle for subcutaneous injection (which the Endocrine Society recognizes as a valid route) reduces discomfort compared to the traditional 21- to 23-gauge intramuscular approach.

Annual all-in cost for TRT in New Hampshire, including medication, labs, supplies, and one to two provider visits, ranges from roughly $600 to $1,800 depending on insurance status and the pricing pathway chosen. The single biggest variable is whether you pay cash or have a commercial plan with a low copay.

Hematocrit monitoring at the 3-month mark is not optional. Polycythemia is the most common adverse effect of exogenous testosterone, reported in 3.4% of patients in TRAVERSE [3], and untreated elevations above 54% increase thrombotic risk.